Health Canada Approves Expanded Production At Aphria

Hello time traveller!!
This article is 2138 days old.
The information listed below is likely outdated and has been preserved for archival purposes.

Health Canada has granted Aphria its license amendment, permitting them to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company’s completed Part IV and Part V expansions.

The 700,000 square foot Part IV Expansion and the 100,000 square foot Part V expansion will produce on an incremental annualized basis 80,000 kg bringing the total annualize production capacity at Aphria One to 110,000 kg.

“This is a major milestone for Aphria on its path to becoming a leading global cannabis producer, as well as a positive development greatly anticipated by the Canadian cannabis industry,” said Irwin D. Simon, Interim CEO of Aphria. “Aphria’s progress expanding production and automation is essential to our strategy of securing scale and long-term advantages that enable the evolution of the cannabis industry through product and brand innovation. With Aphria One, we now have the ability to expand our production capacity by over three times.”

Simon says that by this Friday, they will move swiftly to establish nearly 22,000 plants in the Part IV and Part V expansion, with an additional 12,000 plants added each week thereafter until they reach full crop rotation.